US Oncology buys Cure magazine

US Oncology acquired Cure Media Group, signaling an increased focus on cancer patients. US Oncology is a practice management and drug distribution firm.

Cure Media Group and its flagship magazine title, Cure, were previously owned by Medical Media Holdings, and has a print circulation of around 325,000. Around 176,000 of those issues go out to home subscribers, with the rest going to oncology offices, infusion rooms, nonprofits, hospitals and academic groups.

Editorial staff at Cure, including publisher Susan McClure and editor-at-large Kathy LaTour, will remain in place. Financial terms of the deal were not disclosed.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.